JW Pharmaceutical Corp (001067) — Financial Flexibility Index
JW Pharmaceutical Corp (001067) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of ₩56.71 Billion (operating CF ₩46.92 Billion minus capex ₩9.80 Billion) represents 0% of total liabilities (₩257.46 Billion). Also explore how fast is JW Pharmaceutical Corp growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
JW Pharmaceutical Corp Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for JW Pharmaceutical Corp across 11 annual periods. Check 001067 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for JW Pharmaceutical Corp (2014–2024)
Year-by-year free cash flow to debt coverage for JW Pharmaceutical Corp. For the full company profile including market capitalisation, see how much is JW Pharmaceutical Corp worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.39x | ₩107.53 Billion | ₩79.39 Billion | ₩275.11 Billion | ▲ +16.0% |
| 2023 | 0.34x | ₩127.86 Billion | ₩87.16 Billion | ₩379.60 Billion | ▲ +103.2% |
| 2022 | 0.17x | ₩66.68 Billion | ₩56.76 Billion | ₩402.21 Billion | ▲ +188.0% |
| 2021 | 0.06x | ₩25.59 Billion | ₩18.12 Billion | ₩444.51 Billion | ▼ -73.9% |
| 2020 | 0.22x | ₩75.44 Billion | ₩63.05 Billion | ₩341.62 Billion | ▲ +16.9% |
| 2019 | 0.19x | ₩64.82 Billion | ₩55.53 Billion | ₩343.12 Billion | ▲ +3.8% |
| 2018 | 0.18x | ₩60.75 Billion | ₩52.11 Billion | ₩333.68 Billion | ▲ +60.1% |
| 2017 | 0.11x | ₩40.95 Billion | ₩33.45 Billion | ₩360.10 Billion | ▲ +154.3% |
| 2016 | 0.04x | ₩16.76 Billion | ₩6.74 Billion | ₩374.76 Billion | ▲ +1156.3% |
| 2015 | 0.00x | ₩1.38 Billion | ₩-4.17 Billion | ₩388.07 Billion | ▼ -90.7% |
| 2014 | 0.04x | ₩14.21 Billion | ₩7.28 Billion | ₩369.22 Billion | — |